Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$11.4M Hold
87,800
0.31% 69
2026
Q1
$10.6M Hold
87,800
0.3% 71
2025
Q4
$9.32M Sell
87,800
-9,595
-10% -$901K 0.27% 74
2025
Q3
$8.24M Buy
97,395
+20,625
+27% +$1.7M 0.24% 83
2025
Q2
$6.12M Buy
76,770
+19,291
+34% +$1.53M 0.22% 105
2025
Q1
$5.21M Sell
57,479
-97
-0.2% -$9.06K 0.19% 108
2024
Q4
$5.77M Sell
57,576
-163
-0.3% -$16.8K 0.2% 105
2024
Q3
$6.6M Buy
57,739
+3
+0% +$356 0.24% 102
2024
Q2
$7.19M Sell
57,736
-9
-0% -$1.16K 0.28% 82
2024
Q1
$7.66M Sell
57,745
-162
-0.3% -$20K 0.29% 81
2023
Q4
$6.36M Sell
57,907
-58
-0.1% -$6.02K 0.25% 90
2023
Q3
$6.01M Sell
57,965
-48
-0.1% -$5.17K 0.26% 87
2023
Q2
$6.74M Sell
58,013
-21
-0% -$2.38K 0.28% 77
2023
Q1
$6.22M Sell
58,034
-447
-0.8% -$48.3K 0.26% 86
2022
Q4
$6.54M Sell
58,481
-10,825
-16% -$1.11M 0.28% 74
2022
Q3
$6.02M Buy
+69,306
New +$6.19M 0.27% 74

Other funds holding MRK

Addenda Capital's MRK Position: Q2 2026 in Review

Addenda Capital held its Merck (MRK) position steady in Q2 2026 at 87,800 shares worth $11.4M. The position accounts for 0.31% of the portfolio, ranked #69.

Addenda Capital first reported a position in MRK in Q3 2022 and has held it in 16 quarters since. 711 funds tracked by Wall St. Rank hold MRK as of Q2 2026.

  • Addenda Capital held 87,800 shares of Merck worth $11.4M as of Q2 2026.
  • Addenda Capital left its Merck share count unchanged in Q2 2026.
  • Merck made up 0.31% of Addenda Capital's portfolio in Q2 2026, its #69 holding.
  • Addenda Capital first reported a position in Merck in Q3 2022 and has held it in 16 quarters since.
  • 711 funds tracked by Wall St. Rank held Merck as of Q2 2026.

Based on Addenda Capital's 13F filing for Q2 2026, filed 14 Jul 2026.